Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17130197 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)
Condition: Diabetes Mellitus, Type II
Interventions: Drug: Sitagliptin (MK0431);   Drug: Placebo/Glipizide 5 mg;   Drug: Metformin;   Drug: Pioglitazone

Indicates status has not been verified in more than two years